Effect of morphine on synaptosomal Ca++ uptake. 1979

F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way

The effect of morphine on the uptake of 45Ca++ was studied in synaptosomes from mouse brain using two procedures, centrifugation and filtration. The addition of morphine (1.7 x 10(-7) or 3.4 x 10(-7) M) reduced 45CA++ uptake by either technique, although the basal 45Ca++ uptake by the filtration method was approximately 7-fold higher than that by the centrifugation procedure. Similar effects were obtained after acute morphine treatment with 10 mg/kg s.c. Previous naloxone in vitro treatment (1.9 x 10(-8) M) or in vivo administration (2 mg/kg s.c.) reversed the morphine inhibition of the 45Ca++ uptake. On the other hand, after the animal was rendered tolerant and dependent by morphine pellet implantation, an enhancement of the synaptosomal 45Ca++ uptake was observed. It is concluded that changes in Ca++ fluxes in synaptosomes observed after acute and chronic morphine treatment may be involved with morphine pharmacological action related with analgesia, tolerance and physical dependence.

UI MeSH Term Description Entries
D007981 Levorphanol A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. Levorphan,3-Hydroxy-N-methylmorphinan,L-Dromoran,Levo-Dromoran,Levodroman,Levorphanol Tartrate,3 Hydroxy N methylmorphinan,L Dromoran,Levo Dromoran,LevoDromoran,Tartrate, Levorphanol
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009021 Morphine Dependence Strong dependence, both physiological and emotional, upon morphine. Morphine Abuse,Morphine Addiction,Abuse, Morphine,Addiction, Morphine,Dependence, Morphine
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003917 Dextrorphan Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN. (+-)-17-Methylmorphinan-3-ol
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
January 1989, General pharmacology,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
April 1989, Sheng li xue bao : [Acta physiologica Sinica],
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
June 1983, Japanese journal of pharmacology,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
January 1980, Neurochemical research,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
June 1986, Pharmacology, biochemistry, and behavior,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
November 1981, Biulleten' eksperimental'noi biologii i meditsiny,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
October 1986, Arzneimittel-Forschung,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
July 1980, European journal of pharmacology,
F Guerrero-Munoz, and K V Cerreta, and M L Guerrero, and E L Way
October 1979, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!